1-3 of 3
Charles F. Eisenbeis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma

Khuda D. Khan, Christos Emmanouilides, Don M. Benson, Jr., Deborah Hurst, Pablo Garcia, Glenn Michelson, Sandra Milan, Amy K. Ferketich, Lawrence Piro, John P. Leonard, Pierluigi Porcu, Charles F. Eisenbeis, Amy L. Banks, Lei Chen, John C. Byrd, Michael A. Caligiuri
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (23): 7046–7053.
https://doi.org/10.1158/1078-0432.CCR-06-1571
Published: 04 December 2006
View article titled, A Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma
Open the PDF for A Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma in another window
Journal Articles

Combination Immunotherapy of B-Cell Non-Hodgkin’s Lymphoma with Rituximab and Interleukin-2: A Preclinical and Phase I Study

Charles F. Eisenbeis, Andrew Grainger, Beth Fischer, Robert A. Baiocchi, Lester Carrodeguas, Sameek Roychowdhury, Lei Chen, Amy L. Banks, Thomas Davis, Donn Young, Nicole Kelbick, Julie Stephens, John C. Byrd, Michael R. Grever, Michael A. Caligiuri, Pierluigi Porcu
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (18): 6101–6110.
https://doi.org/10.1158/1078-0432.CCR-04-0525
Published: 24 September 2004
View article titled, Combination Immunotherapy of B-Cell Non-Hodgkin’s Lymphoma with Rituximab and Interleukin-2: <subtitle>A Preclinical and Phase I Study</subtitle>
Open the PDF for Combination Immunotherapy of B-Cell Non-Hodgkin’s Lymphoma with Rituximab and Interleukin-2: <subtitle>A Preclinical and Phase I Study</subtitle> in another window
Journal Articles

Rituximab: Converging Mechanisms of Action in Non-Hodgkin’s Lymphoma?

Charles F. Eisenbeis, Michael A. Caligiuri, John C. Byrd
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5810–5812.
Published: 15 December 2003
View article titled, Rituximab: <subtitle>Converging Mechanisms of Action in Non-Hodgkin’s Lymphoma?</subtitle>
Open the PDF for Rituximab: <subtitle>Converging Mechanisms of Action in Non-Hodgkin’s Lymphoma?</subtitle> in another window